PAREXEL International to Present at JP Morgan Healthcare Conference
BOSTON, January 4, 2016 – PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Wednesday, January 13, 2016, in San Francisco. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 11:00 a.m. PT.
A live webcast of the presentation will be available through the “Investors” section of PAREXEL’s website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website for 90 days after the presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 80 locations in 51 countries around the world, and had approximately 18,620 employees in the first quarter. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.
CONTACTS: Ingo Bank, Senior Vice President and Chief Financial Officer
Investor Relations IR@PAREXEL.com +1-781-434-4118